1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer : Big Data Analytics Using the PIONEER Platform
(
- Contribution to journal › Article
- 2023
-
Mark
How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis
(
- Contribution to journal › Article
- 2021
-
Mark
Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer
2021) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 62(7). p.989-995(
- Contribution to journal › Article
-
Mark
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Introducing PIONEER : a project to harness big data in prostate cancer research
(
- Contribution to journal › Article
-
Mark
Targeted alpha therapy in a systemic mouse model of prostate cancer - a feasibility study
(
- Contribution to journal › Article
- 2019
-
Mark
Preserving Preclinical PET Quality During Intratherapeutic Imaging in Radionuclide Therapy with Rose Metal Shielding Reducing Photon Flux
(
- Contribution to journal › Article
- 2018
-
Mark
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
(
- Contribution to journal › Article
- 2017
-
Mark
An attenuation method for reducing count rate losses in preclinical PET during intratherapeutic imaging
2017) 2016 IEEE Nuclear Science Symposium, Medical Imaging Conference and Room-Temperature Semiconductor Detector Workshop, NSS/MIC/RTSD 2016 2017-January.(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
(
- Contribution to journal › Article